Molecular Targeting Technology Inc.
Executive Summary
Molecular Targeting Technology is developing radiopharmaceuticals for nuclear medicine and targeting agents for drug delivery. The company's lead product, {Amiscan} uses a small-molecule radiotracer to diagnose heart attack.